Form 4 holding
CMO, Hematology
BeiGene, Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 160,055
- Estimated value
- $33,246,160
- Report date
- 14 Dec 2021
- Price
- $207.72
- Ownership
- Direct
Jane Huang - CMO, Hematology at BeOne Medicines Ltd.
Issuer-level insider activity
- Role
- CMO, Hematology
- Issuer ticker
- ONC on Nasdaq, BEIGF on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jane Huang since 13 Sep 2025
Reported holdings for Jane Huang in BeOne Medicines Ltd.
Form 4 holding
CMO, Hematology
BeiGene, Ltd.
- Security class
- Share Option (Right to Buy)
- Shares / value
- 211,276
- Estimated value
- Report date
- 14 Dec 2021
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
CMO, Hematology
BeiGene, Ltd.
- Security class
- American Depositary Shares
- Shares / value
- 0
- Estimated value
- Report date
- 14 Dec 2021
- Price
- $180.50
- Ownership
- Direct
Transaction history for Jane Huang in BeOne Medicines Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.